2019 annual financial data
Inhibikase Therapeutics 2019 Operating margin
Inhibikase Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -507.52%.
Operating income was -5,698,148 USD and net income was -5,747,818 USD.
Operating cash flow was -338,290 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,122,740 USD
- Operating income
- -5,698,148 USD
- Net income
- -5,747,818 USD
- Operating cash flow
- -338,290 USD